Suppr超能文献

基于前药的基因沉默方法中的刺激响应性寡核苷酸。

Stimuli-responsive oligonucleotides in prodrug-based approaches for gene silencing.

作者信息

Debart Françoise, Dupouy Christelle, Vasseur Jean-Jacques

机构信息

IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.

出版信息

Beilstein J Org Chem. 2018 Feb 19;14:436-469. doi: 10.3762/bjoc.14.32. eCollection 2018.

Abstract

Oligonucleotides (ONs) have been envisaged for therapeutic applications for more than thirty years. However, their broad use requires overcoming several hurdles such as instability in biological fluids, low cell penetration, limited tissue distribution, and off-target effects. With this aim, many chemical modifications have been introduced into ONs definitively as a means of modifying and better improving their properties as gene silencing agents and some of them have been successful. Moreover, in the search for an alternative way to make efficient ON-based drugs, the general concept of prodrugs was applied to the oligonucleotide field. A prodrug is defined as a compound that undergoes transformations in vivo to yield the parent active drug under different stimuli. The interest in stimuli-responsive ONs for gene silencing functions has been notable in recent years. The ON prodrug strategies usually help to overcome limitations of natural ONs due to their low metabolic stability and poor delivery. Nevertheless, compared to permanent ON modifications, transient modifications in prodrugs offer the opportunity to regulate ON activity as a function of stimuli acting as switches. Generally, the ON prodrug is not active until it is triggered to release an unmodified ON. However, as it will be described in some examples, the opposite effect can be sought. This review examines ON modifications in response to various stimuli. These stimuli may be internal or external to the cell, chemical (glutathione), biochemical (enzymes), or physical (heat, light). For each stimulus, the discussion has been separated into sections corresponding to the site of the modification in the nucleotide: the internucleosidic phosphate, the nucleobase, the sugar or the extremities of ONs. Moreover, the review provides a current and detailed account of stimuli-responsive ONs with the main goal of gene silencing. However, for some stimuli-responsive ONs reported in this review, no application for controlling gene expression has been shown, but a certain potential in this field could be demonstrated. Additionally, other applications in different domains have been mentioned to extend the interest in such molecules.

摘要

三十多年来,人们一直设想将寡核苷酸(ONs)用于治疗应用。然而,它们的广泛应用需要克服几个障碍,如在生物流体中的不稳定性、低细胞穿透性、有限的组织分布和脱靶效应。出于这个目的,许多化学修饰已被明确引入到ONs中,作为修饰和更好地改善其作为基因沉默剂的性质的一种手段,其中一些已经取得了成功。此外,在寻找制造高效基于ON的药物的替代方法时,前药的一般概念被应用于寡核苷酸领域。前药被定义为一种在体内发生转化以在不同刺激下产生母体活性药物的化合物。近年来,对用于基因沉默功能的刺激响应性ONs的兴趣显著。ON前药策略通常有助于克服天然ONs由于其低代谢稳定性和较差的递送而存在的局限性。然而,与永久性ON修饰相比,前药中的瞬时修饰提供了根据作为开关的刺激来调节ON活性的机会。一般来说,ON前药在被触发释放未修饰的ON之前是无活性的。然而,正如在一些例子中将描述的那样,也可以寻求相反的效果。本综述研究了响应各种刺激的ON修饰。这些刺激可能是细胞内部或外部的、化学的(谷胱甘肽)、生化的(酶)或物理的(热、光)。对于每种刺激,讨论已分为对应于核苷酸中修饰位点的部分:核苷间磷酸、核苷碱基、糖或ON的末端。此外,本综述提供了关于以基因沉默为主要目标的刺激响应性ONs的最新详细说明。然而,对于本综述中报道的一些刺激响应性ONs,尚未显示出用于控制基因表达的应用,但在该领域可能具有一定潜力。此外,还提到了在不同领域的其他应用,以扩展对此类分子的兴趣。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc72/5827813/f3f514f1ed34/Beilstein_J_Org_Chem-14-436-g007.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验